193 related articles for article (PubMed ID: 33105674)
1. Generation of a hTERT-Immortalized Human Sertoli Cell Model to Study Transporter Dynamics at the Blood-Testis Barrier.
Hau RK; Miller SR; Wright SH; Cherrington NJ
Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33105674
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
[TBL] [Abstract][Full Text] [Related]
3. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
[TBL] [Abstract][Full Text] [Related]
4. Basolateral uptake of nucleosides by Sertoli cells is mediated primarily by equilibrative nucleoside transporter 1.
Klein DM; Evans KK; Hardwick RN; Dantzler WH; Wright SH; Cherrington NJ
J Pharmacol Exp Ther; 2013 Jul; 346(1):121-9. PubMed ID: 23639800
[TBL] [Abstract][Full Text] [Related]
5. Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier.
Hau RK; Klein RR; Wright SH; Cherrington NJ
Drug Metab Dispos; 2022 Jun; 50(6):770-780. PubMed ID: 35307651
[TBL] [Abstract][Full Text] [Related]
6. Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites.
Miller SR; McGrath ME; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Dec; 100(6):548-557. PubMed ID: 34503974
[TBL] [Abstract][Full Text] [Related]
7. Physiological Characterization of the Transporter-Mediated Uptake of the Reversible Male Contraceptive H2-Gamendazole Across the Blood-Testis Barrier.
Hau RK; Tash JS; Georg GI; Wright SH; Cherrington NJ
J Pharmacol Exp Ther; 2022 Sep; 382(3):299-312. PubMed ID: 35779861
[TBL] [Abstract][Full Text] [Related]
8. Testicular disposition of clofarabine in rats is dependent on equilibrative nucleoside transporters.
Miller SR; Jilek JL; McGrath ME; Hau RK; Jennings EQ; Galligan JJ; Wright SH; Cherrington NJ
Pharmacol Res Perspect; 2021 Aug; 9(4):e00831. PubMed ID: 34288585
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and In Vivo Models for Drug Transport Across the Blood-Testis Barrier.
Hau RK; Wright SH; Cherrington NJ
Drug Metab Dispos; 2023 Sep; 51(9):1157-1168. PubMed ID: 37258305
[TBL] [Abstract][Full Text] [Related]
10. Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2.
Noguchi S; Takagi A; Tanaka T; Takahashi Y; Pan X; Kibayashi Y; Mizokami R; Nishimura T; Tomi M
Biopharm Drug Dispos; 2021 Mar; 42(2-3):85-93. PubMed ID: 33426680
[TBL] [Abstract][Full Text] [Related]
11. Drug Transporters at the Human Blood-Testis Barrier.
Hau RK; Wright SH; Cherrington NJ
Drug Metab Dispos; 2023 May; 51(5):560-571. PubMed ID: 36732077
[TBL] [Abstract][Full Text] [Related]
12. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
Hammond JR
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
[TBL] [Abstract][Full Text] [Related]
13. Xenobiotic and endobiotic transporter mRNA expression in the blood-testis barrier.
Augustine LM; Markelewicz RJ; Boekelheide K; Cherrington NJ
Drug Metab Dispos; 2005 Jan; 33(1):182-9. PubMed ID: 15494472
[TBL] [Abstract][Full Text] [Related]
14. Blood-to-Testis Transport of Ribavirin Involves Carrier-Mediated Processes at the Blood-Testis Barrier.
Ito T; Kubo Y; Tega Y; Akanuma SI; Hosoya KI
J Pharm Sci; 2024 Apr; ():. PubMed ID: 38679231
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside transport at the blood-testis barrier studied with primary-cultured sertoli cells.
Kato R; Maeda T; Akaike T; Tamai I
J Pharmacol Exp Ther; 2005 Feb; 312(2):601-8. PubMed ID: 15547112
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of equilibrative and concentrative nucleoside transporters in alveolar epithelial cells.
Baba S; Yumoto R; Kawami M; Takano M
Pharmazie; 2021 Sep; 76(9):416-421. PubMed ID: 34481531
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine.
Tang PCT; Yang C; Li RW; Lee SM; Hoi MP; Chan SW; Kwan YW; Tse CM; Leung GP
Eur J Pharmacol; 2016 Nov; 791():544-551. PubMed ID: 27388143
[TBL] [Abstract][Full Text] [Related]
18. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
Ward JL; Sherali A; Mo ZP; Tse CM
J Biol Chem; 2000 Mar; 275(12):8375-81. PubMed ID: 10722669
[TBL] [Abstract][Full Text] [Related]
19. Quantification of ENT1 and ENT2 Proteins at the Placental Barrier and Contribution of These Transporters to Ribavirin Uptake.
Nishimura T; Sano Y; Takahashi Y; Noguchi S; Uchida Y; Takagi A; Tanaka T; Katakura S; Nakashima E; Tachikawa M; Maruyama T; Terasaki T; Tomi M
J Pharm Sci; 2019 Dec; 108(12):3917-3922. PubMed ID: 31520644
[TBL] [Abstract][Full Text] [Related]
20. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line.
Crawford CR; Patel DH; Naeve C; Belt JA
J Biol Chem; 1998 Feb; 273(9):5288-93. PubMed ID: 9478986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
